InvestorsHub Logo
Followers 21
Posts 1141
Boards Moderated 0
Alias Born 02/11/2012

Re: None

Saturday, 06/14/2014 11:45:07 PM

Saturday, June 14, 2014 11:45:07 PM

Post# of 42929
Ok. So on December 13, 2013 they mentioned they were going to conduct a 6 month study to confirm the optimum dosage. I am assuming that that study is close to being completed. Maybe NEWS next week on this study.

https://www.facebook.com/photo.php?fbid=587591478000169&set=pb.578123755613608.-2207520000.1402803464.&type=3&theater

Here is a link to the license agreement struck with Northstar PR.

Northstar acquires a new and exciting patent license in a multi-billion dollar industry

http://www.prnewswire.com/news-releases/northstar-acquires-a-new-and-exciting-patent-license-in-a-multi-billion-dollar-industry-209327661.html

This Northstar PR was dated May 2013. Possible the shares Manza received from the Northstar license are what is funding the purchase of the shell FOGC, the Attorney letters, filings, studies, marketing, and PR's. Apparently, Northstar really liked the patented process for Lactose intolerance products.



Also, I would expect some reduction of shares. I expect good things in the coming weeks and months. IMO

GLTA